本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ligand Pharmaceuticals Inc.

305.22
-5.9100-1.90%
成交量:7.31万
成交额:2,241.04万
市值:60.85亿
市盈率:31.43
高:311.72
开:311.72
低:304.30
收:311.13
52周最高:326.63
52周最低:175.89
股本:1,993.56万
流通股本:1,935.39万
量比:0.59
换手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):9.71
每股收益(LYR):6.13
净资产收益率:21.96%
总资产收益率:3.99%
市净率:6.29
市盈率(LYR):49.79

数据加载中...

2020/08/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/03

重要事件披露

8-K - Current report
2020/06/11

重要事件披露

8-K - Current report
2020/05/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/07

重要事件披露

Current report, item 1.01
2020/04/06

重要事件披露

Current report, items 2.02 and 8.01
2020/04/02

重要事件披露

Current report, items 8.01 and 9.01
2020/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

重要事件披露

Current report, items 2.02 and 9.01
2020/01/10

超过5%披露

Statement of acquisition of beneficial ownership by individuals